Using the direct and diffuse solar radiation data during 1961—2009 from 14 stations and during 1961—1991 from 49 stations in China, and the method of linear regression (taken time as an independent variable), wavelet analysis and Mann-Kendall statistical test, we analyze the characteristics of the direct and diffusion radiation from different aspects including decadal variation, long-term seasonal change, inter-decadal anomaly, cycle and abrupt change. The results are as follows. 1) The spatial and temporal distribution of the climatic trend for the direct and diffuse radiation are revealed by using the normalized climatic tendency coefficient. At the same time, these results are comparable. 2) The direct solar and diffuse radiation in China show decreasing trend, but there are many differences in region, inter-annual and seasonal trend. 3) Based on the characteristics of the geographical distribution on observation stations and according to the climate zone, the classification and the statistical analysis of the percentage of site occupation the long-term changes of the radiation can be clearly shown to have the characteristics of area and local difference. 4) Using wavelet and Mann-Kendall test method, the statistical results show that the radiations in different regions have different periods and abrupt change. 5)The long-term variations of the direct and diffuse radiation in most big cities turn to decrease more obviously than in other cities. Some. Other studies show that such a climatic phenomenon may be caused by environmental factor change of urbanization related to the difference in development speed between cities.
AimAs a primary cause of death not only in Western countries but also in the People’s Republic of China, sepsis is diagnosed as abnormal organ functions as a result of a disordered response to a severe infection. This study was designed to assess the effect of small-dose levosimendan without a loading dose on mortality rates and organ functions in Chinese elderly patients with sepsis.MethodsFollowing a prospective, randomized, and double-blinded design, 240 Chinese elderly patients with sepsis shock were admitted to the intensive care unit (ICU). All patients were randomly and evenly assigned into a levosimendan group (number of patients =120) and a control group (number of patients =120). The control group underwent standard care, and the levosimendan group was administered levosimendan in addition to standard care.ResultsAll participants, comprising 134 males (55.8%) and 106 females (44.2%), were 70 (67–73) years old. Baseline characteristics, preexisting illnesses, initial infections, organ failures, and additional agents and therapies showed no significant difference between the two groups (P>0.05 for all). There were no significant differences in mortality rates at 28 days, at ICU discharge, and at hospital discharge between the two groups (P>0.05 for all). The number of days of ICU and hospital stay in the levosimendan group was significantly less than for those in the control group (P<0.05 for all). Mean daily total sequential organ failure assessment score and all organ scores except the cardiovascular scores showed no significant difference between the two groups (P>0.05 for all). Cardiovascular scores in the levosimendan group were significantly higher than those in the control group (P<0.05 for all).ConclusionSmall-dose levosimendan could not reduce the mortality rates or enhance the respiratory, liver, renal, and coagulation functions, but could shorten the days of ICU and hospital stay, and improve the cardiovascular function, which suggests that small-dose levosimendan is valuable for Chinese elderly patients with sepsis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.